PW Medtech Group Ltd
HKEX:1358
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.91
1.61
|
| Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
PW Medtech Group Ltd
Cash from Operating Activities
PW Medtech Group Ltd
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
P
|
PW Medtech Group Ltd
HKEX:1358
|
Cash from Operating Activities
ÂĄ283.9m
|
CAGR 3-Years
28%
|
CAGR 5-Years
19%
|
CAGR 10-Years
6%
|
|
|
A
|
APT Medical Inc
SSE:688617
|
Cash from Operating Activities
ÂĄ743.4m
|
CAGR 3-Years
60%
|
CAGR 5-Years
68%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Cash from Operating Activities
ÂĄ1.9B
|
CAGR 3-Years
15%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
16%
|
|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Cash from Operating Activities
ÂĄ8.6B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
L
|
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
|
Cash from Operating Activities
ÂĄ1.3B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
13%
|
|
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Cash from Operating Activities
-ÂĄ619m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
PW Medtech Group Ltd
Glance View
PW Medtech Group Ltd. is an investment holding company, which engages in the manufacture and sale of infusion set products. The company is headquartered in Beijing, Beijing and currently employs 670 full-time employees. The company went IPO on 2013-11-08. The firm operates through three business segments. The Infusion Set Business segment is engaged in the manufacturing and sales of infusion sets. The Orthopedic Implant Business segment is engaged in the manufacturing and sales of orthopedic implant products, including product category of trauma, spine and joints. The Regenerative Medical Biomaterial Business segment is engaged in the manufacturing and sales of regenerative medical biomaterial products.
See Also
What is PW Medtech Group Ltd's Cash from Operating Activities?
Cash from Operating Activities
283.9m
CNY
Based on the financial report for Jun 30, 2025, PW Medtech Group Ltd's Cash from Operating Activities amounts to 283.9m CNY.
What is PW Medtech Group Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
6%
Over the last year, the Cash from Operating Activities growth was 5%. The average annual Cash from Operating Activities growth rates for PW Medtech Group Ltd have been 28% over the past three years , 19% over the past five years , and 6% over the past ten years .